Literature DB >> 8270647

Chediak-Higashi syndrome is not due to a defect in microtubule-based lysosomal mobility.

C M Perou1, J Kaplan.   

Abstract

Chediak-Higashi Syndrome is an autosomal recessive disorder that affects intracellular vesicle formation. The diagnostic feature of Chediak-Higashi Syndrome is the presence of 'giant' lysosomes clustered near the nucleus. Lysosome morphology in macrophages is maintained by microtubules and microtubule-based motors, such as kinesin. Dramatic changes in lysosome morphology can be induced by lowering cytoplasmic pH or by adding phorbol esters. When macrophages from beige mice (a murine homolog of Chediak-Higashi Syndrome) were subjected to these protocols they were able to alter their lysosomal distribution and morphology to the same degree as macrophages from control mice. These results indicate that lysosomes in Chediak cells are capable of interacting with the microtubule-based motor system, suggesting that the defective gene product is not an altered microtubular element involved in lysosomal movement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270647     DOI: 10.1242/jcs.106.1.99

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  11 in total

1.  Mon1a protein acts in trafficking through the secretory apparatus.

Authors:  Dustin C Bagley; Prasad N Paradkar; Jerry Kaplan; Diane M Ward
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  The late chlamydial inclusion membrane is not derived from the endocytic pathway and is relatively deficient in host proteins.

Authors:  T Taraska; D M Ward; R S Ajioka; P B Wyrick; S R Davis-Kaplan; C H Davis; J Kaplan
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

3.  Enlarged dysmorphic lysosomes in an established beige (C57BL/6J;bgJ(/bgJ)) mouse mutant fibroblast line: a reversible characteristic.

Authors:  J B Gow; T A Lyerla; S Lainwala
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

4.  The enlarged lysosomes in beige j cells result from decreased lysosome fission and not increased lysosome fusion.

Authors:  Nina Durchfort; Shane Verhoef; Michael B Vaughn; Rishna Shrestha; Dieter Adam; Jerry Kaplan; Diane McVey Ward
Journal:  Traffic       Date:  2011-11-09       Impact factor: 6.215

5.  Defective surfactant secretion in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Susan H Guttentag; Amana Akhtar; Jian-Qin Tao; Elena Atochina; Michael E Rusiniak; Richard T Swank; Sandra R Bates
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-24       Impact factor: 6.914

6.  Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4-Deficient Cells.

Authors:  Jianlong Zou; Bo Hu; Sezgi Arpag; Qing Yan; Audra Hamilton; Yuan-Shan Zeng; Carlos G Vanoye; Jun Li
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

7.  Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport.

Authors:  A Rodríguez; E Samoff; M G Rioult; A Chung; N W Andrews
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

8.  The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease.

Authors:  Irene E Zohn; Ivana De Domenico; Andrew Pollock; Diane McVey Ward; Jessica F Goodman; Xiayun Liang; Amaru J Sanchez; Lee Niswander; Jerry Kaplan
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

9.  Molecular and clinical correlates in iron overload associated with mutations in ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Elizabeta Nemeth; Tomas Ganz; Elena Corradini; Francesca Ferrara; Giovanni Musci; Antonello Pietrangelo; Jerry Kaplan
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

10.  Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome.

Authors:  W Faigle; G Raposo; D Tenza; V Pinet; A B Vogt; H Kropshofer; A Fischer; G de Saint-Basile; S Amigorena
Journal:  J Cell Biol       Date:  1998-06-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.